Pediatric Neurology

The prevalence of intraventricular hemorrhage among preterm infants has not changed over time, but it occurs later in life than it did 20 to 30 years ago, according to the results of a large study published in JAMA Pediatrics.

LOS ANGELES — A wearable, behind-the-ear EEG device is feasible for assessment of sleep patterns in young people with Dravet syndrome, according to a poster presented at the American Epilepsy Society annual meeting.

LOS ANGELES — Zorevunersen led to 75% to 80% seizure reduction in patients with Dravet syndrome, according to Barry S. Ticho, MD, PhD, FACC, chief medical officer of Stoke Therapeutics.

Health Canada has approved Daybue to treat Rett syndrome in patients aged 2 years and older, according to manufacturer Acadia Pharmaceuticals.

PHILADELPHIA — In this video, Michael Fisher, MD, highlights the sessions and presentations at the International Symposium on Pediatric Neuro-Oncology.

Seizure frequency was reduced as much as 85% at 3 months in young patients with Dravet syndrome treated with a proprietary antisense oligonucleotide, according to results of phase 1/2a studies released by the manufacturer.

Treatment with apitegromab was linked to improved muscle strength and range of motion, while being safe and well-tolerated in those with spinal muscular atrophy types 2 and 3, according to a poster presentation.

In this Healio video, Robert C. Stowe, MD, an instructor of neurology at Boston Children’s Hospital and Harvard Medical School, discusses a new perspective on how sleep and circadian rhythms influence seizures.

In this Healio video, Robert C. Stowe, MD, an instructor of neurology at Boston Children’s Hospital and Harvard Medical School, discusses highlights from a session at the Child Neurology Society annual meeting.

Robert C. Stowe, MD, an instructor of neurology at Boston Children’s Hospital and Harvard Medical School, discusses key features from his session at the Child Neurology Society annual meeting in this Healio video.